Ashraf Amanullah
Keine laufenden Positionen mehr
Aktive Positionen von Ashraf Amanullah
| Unternehmen | Position | Beginn | Ende |
|---|
Karriereverlauf von Ashraf Amanullah
Ehemalige bekannte Positionen von Ashraf Amanullah
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| INHIBRX, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2018 | 30.05.2024 |
| ATYR PHARMA, INC. | Corporate Officer/Principal | 01.11.2015 | 01.07.2018 |
| GILEAD SCIENCES, INC. | Direktor/Vorstandsmitglied | 01.09.2011 | 01.08.2015 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.09.2006 | 01.08.2011 |
Ausbildung von Ashraf Amanullah
| The University of Sheffield | Doctorate Degree |
| University of Birmingham | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Vereinigtes Königreich | 3 |
Operativ
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ATYR PHARMA, INC. | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
| INHIBRX, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Börse
- Insiders
- Ashraf Amanullah
- Erfahrung